CA1211374A - Pharmaceutical compositions containing more active ingredients - Google Patents
Pharmaceutical compositions containing more active ingredientsInfo
- Publication number
- CA1211374A CA1211374A CA000427820A CA427820A CA1211374A CA 1211374 A CA1211374 A CA 1211374A CA 000427820 A CA000427820 A CA 000427820A CA 427820 A CA427820 A CA 427820A CA 1211374 A CA1211374 A CA 1211374A
- Authority
- CA
- Canada
- Prior art keywords
- weight
- cimetidine
- ulcer
- agent
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU1536/82 | 1982-05-14 | ||
HU153582 | 1982-05-14 | ||
HU1535/82 | 1982-05-14 | ||
HU153682A HU188167B (en) | 1982-05-14 | 1982-05-14 | Process for producing new pharmaceutical compositions against ulcer |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1211374A true CA1211374A (en) | 1986-09-16 |
Family
ID=26317386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000427820A Expired CA1211374A (en) | 1982-05-14 | 1983-05-10 | Pharmaceutical compositions containing more active ingredients |
Country Status (13)
Country | Link |
---|---|
AR (1) | AR230570A1 (xx) |
AU (1) | AU1459183A (xx) |
BE (1) | BE896711A (xx) |
CA (1) | CA1211374A (xx) |
CH (1) | CH655243A5 (xx) |
DD (1) | DD209735A5 (xx) |
DE (1) | DE3317578A1 (xx) |
DK (1) | DK215883D0 (xx) |
FI (1) | FI831687L (xx) |
FR (1) | FR2527078B1 (xx) |
GB (1) | GB2120938B (xx) |
NL (1) | NL8301722A (xx) |
SE (1) | SE8302689L (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0189788B1 (de) * | 1985-01-23 | 1989-09-13 | ASTA Pharma Aktiengesellschaft | Synergistische Kombination von Flupirtin und nicht-steroidalen Antiphlogistika |
US5260333A (en) * | 1986-08-08 | 1993-11-09 | Bristol Myers Squibb Company | Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions |
GB8625325D0 (en) * | 1986-10-22 | 1986-11-26 | Glaxo Group Ltd | Chemical compounds |
GB8629781D0 (en) * | 1986-12-12 | 1987-01-21 | Glaxo Group Ltd | Pharmaceutical compositions |
GB8904182D0 (en) * | 1989-02-23 | 1989-04-05 | Glaxo Canada | Pharmaceutical compositions |
WO1992015332A1 (en) * | 1991-03-04 | 1992-09-17 | Warner-Lambert Company | Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms |
ES2130152T3 (es) * | 1991-12-06 | 1999-07-01 | Glaxo Group Ltd | Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto. |
HU213101B (en) * | 1992-12-29 | 1997-02-28 | Richter Gedeon Vegyeszet | Process for producing pharmaceutical composition of synergetic gastrocitoprotective activity, containing ranitidine and derivative of the salicylic acid |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU170329B (xx) * | 1974-12-12 | 1977-05-28 | ||
US4198402A (en) * | 1975-12-17 | 1980-04-15 | Richter Gedeon Vegyeszeti Gyar Rt. | Antiphlogistic composition of phenylbutozone and alkali salicylate and method of treatment |
US4200631A (en) * | 1975-12-17 | 1980-04-29 | Richter Gedeon Vegyeszeti Gyar Rt. | Treating mammalian subject sensitive to indomethacin ulcerogenisis |
NZ196349A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered polar bioactive agents |
-
1983
- 1983-05-10 BE BE0/210740A patent/BE896711A/fr not_active IP Right Cessation
- 1983-05-10 CA CA000427820A patent/CA1211374A/en not_active Expired
- 1983-05-10 SE SE8302689A patent/SE8302689L/xx not_active Application Discontinuation
- 1983-05-13 DD DD25091383A patent/DD209735A5/de not_active IP Right Cessation
- 1983-05-13 DE DE19833317578 patent/DE3317578A1/de not_active Withdrawn
- 1983-05-13 FI FI831687A patent/FI831687L/fi not_active Application Discontinuation
- 1983-05-13 DK DK215883A patent/DK215883D0/da not_active Application Discontinuation
- 1983-05-13 GB GB08313269A patent/GB2120938B/en not_active Expired
- 1983-05-13 CH CH262683A patent/CH655243A5/de not_active IP Right Cessation
- 1983-05-13 FR FR8307985A patent/FR2527078B1/fr not_active Expired
- 1983-05-13 NL NL8301722A patent/NL8301722A/nl not_active Application Discontinuation
- 1983-05-13 AU AU14591/83A patent/AU1459183A/en not_active Abandoned
- 1983-05-13 AR AR29301383A patent/AR230570A1/es active
Also Published As
Publication number | Publication date |
---|---|
FR2527078A1 (fr) | 1983-11-25 |
CH655243A5 (de) | 1986-04-15 |
SE8302689D0 (sv) | 1983-05-10 |
DK215883D0 (da) | 1983-05-13 |
DE3317578A1 (de) | 1983-12-01 |
FI831687L (fi) | 1983-11-15 |
FI831687A0 (fi) | 1983-05-13 |
GB2120938B (en) | 1985-09-18 |
FR2527078B1 (fr) | 1987-06-12 |
BE896711A (fr) | 1983-09-01 |
GB2120938A (en) | 1983-12-14 |
DD209735A5 (de) | 1984-05-23 |
NL8301722A (nl) | 1983-12-01 |
GB8313269D0 (en) | 1983-06-22 |
AR230570A1 (es) | 1984-05-31 |
SE8302689L (sv) | 1983-11-15 |
AU1459183A (en) | 1983-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2811353B2 (ja) | 炎症性腸疾患予防・治療剤 | |
JP3305315B2 (ja) | 動物及び人間の疼痛及び/又は炎症の抑制時における薬剤ならびにその製造及びその使用 | |
US6017932A (en) | Pharmaceutical compositions containing at least one NSAID having increased bioavailability | |
JP3260378B2 (ja) | 腸感染に対する薬物の調製のためのフマギロールおよびその誘導体の使用 | |
DE2711493C2 (xx) | ||
CA1211374A (en) | Pharmaceutical compositions containing more active ingredients | |
JPS6056920A (ja) | 脂質レベルの低減方法 | |
US5234927A (en) | Solid pharmaceutical composition for oral administration containing dapiprazole | |
US11738032B2 (en) | Pharmaceutical formulation for the treatment of inflammatory changes to the rectum | |
JPH01265027A (ja) | 肝疾患治療剤 | |
US3462534A (en) | Production of an antidepressant effect with esters of gallic acid | |
EP2123277B1 (en) | Preventive or therapeutic agent for inflammatory bowel disease | |
CA1177755A (en) | Pharmaceutical composition having antiphlogistic, antipyretic and analgesic activity | |
EP0059031B1 (en) | Analgesic and anti-inflammatory composition | |
NZ193239A (en) | Anti-inflammatory compositions containing 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid and a 2-hydroxy-5-halophenylbenzoic acid derivative | |
US4470974A (en) | Gastric cytoprotection with L-363,586 | |
JP3386873B2 (ja) | 消化器系疾患用剤 | |
AU2017384442B2 (en) | Oral ibuprofen preparation | |
IL44618A (en) | Pharmaceutical compositions comprising mixed salts of polysulfuric esters of naturally occurring glycopeptides with metals and organic bases | |
JPS6313964B2 (xx) | ||
JPH0535131B2 (xx) | ||
JPS6149290B2 (xx) | ||
JPS643168B2 (xx) | ||
US3833734A (en) | P-phenylenediamines as hypolipidemics | |
GB1565447A (en) | Pharmaceutical preparations for venotonic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |